Skip to main content

Table 3 Common variant association results.

From: Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes

Variant information

Discovery

Replication stage 1 and 2 (combined)

Location

Substitution

Gene

Functional annotation

Protein

dbSNP129

Alleles cases

Alleles controls

p =

Effective sample size cases

MAF cases, % (n)

Effective sample size controls

MAF controls, % (n)

p=

OR

95% CI

chr4:155727040

T > C

FGA

exon - missense

p.T331A

rs6050

10

4

0.004

709

32 (453)

702

22 (312)

1.9 × 10-5

1.45

1.22-1.72

chr16:80474413

A > G

PLCG2

exon - missense

p.H244R

rs11548656

4

0

0.013

711

6 (88)

705

6 (83)

0.73

1.05

0.77-1.43

chr4:122837138

T > C

ANXA5

Intron

Na

rs2306416

4

0

0.013

139

15 (41)

138

15 (42)

0.97

0.96

0.60-1.54

chr8:42164111

G > A

PLAT

exon - synonymous

Na

rs1058720

11

3

0.002

139

47 (131)

139

44 (124)

0.61

1.10

0.79-1.54

chr11:47311481

T > C

MYBPC3

Intron

Na

rs11570115

5

0

0.004

137

11 (30)

139

9 (26)

0.63

1.19

0.68-2.07

  1. MAF indicates minor allele frequency; OR, odds ratio; CI, confidence interval; Na, not applicable (the variant does not cause protein sequence changes).